Ara Parseghian Medical Research Foundation

The Ara Parseghian Medical Research Foundation's purpose is to promote Research that is targeted toward understanding the molecular basis of niemann pick type c (np-c) disease and developing novel therapeutic strategies to treat and/or cure the disease. As np-c disease appears to be caused by a defect in intracellular cholesterol trafficking, these studies should provide fundamental insights into cholesterol homeostasis and as such will also serve to increase understanding of atherosclerosis and myocardial infarction, the leading cause of morbidity and mortality in the united states. In the year ended june 30, 2017, the organization awarded Research grants to 1 major Research university.